On the other hand, other studies reported that long term (1 to 6 months) administration of 1.5 g/d to 1.7 g/d metformin increased insulin sensitivity (43%) in obese PCOS subjects but did not have any effect on BMI and WHR (Table 3) (15, 20, 21). This evidence concerns the gene INS and polycystic ovary syndrome.